Fisher & Paykel Healthcare Corporation Limited
FSPKF
$16.35
-$0.5832-3.44%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 108.57M | 94.19M | 81.02M | 121.88M | 160.89M |
| Total Depreciation and Amortization | 74.27M | 70.12M | 66.55M | 63.46M | 60.05M |
| Total Amortization of Deferred Charges | 3.16M | 3.16M | 3.16M | 3.18M | 3.15M |
| Total Other Non-Cash Items | 104.32M | 103.98M | 103.66M | 57.72M | 12.27M |
| Change in Net Operating Assets | 17.52M | 12.50M | 7.46M | 6.36M | 5.16M |
| Cash from Operations | 307.84M | 283.95M | 261.85M | 252.60M | 241.52M |
| Capital Expenditure | -56.26M | -123.99M | -193.60M | -201.26M | -208.19M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15.88M | -14.65M | -13.54M | -13.67M | -13.70M |
| Cash from Investing | -72.14M | -138.63M | -207.14M | -214.93M | -221.89M |
| Total Debt Issued | 130.60M | 215.60M | 300.60M | 310.30M | 320.00M |
| Total Debt Repaid | -314.50M | -300.65M | -286.80M | -242.75M | -198.70M |
| Issuance of Common Stock | 3.30M | 3.15M | 3.00M | 2.80M | 2.60M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -75.47M | -73.79M | -72.80M | -77.02M | -80.65M |
| Other Financing Activities | -27.22M | -26.71M | -26.20M | -21.20M | -16.20M |
| Cash from Financing | -201.88M | -139.97M | -78.06M | -46.64M | -14.91M |
| Foreign Exchange rate Adjustments | -2.25M | -449.30K | 1.34M | -409.90K | -2.10M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 31.57M | 4.89M | -22.01M | -9.38M | 2.62M |
